NREP
NEW REPRESENTATIVE AT IB RECEIVED
14/11/2025
Voltar para busca
Dado oficial do USPTO
DUOSPORE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
15/11/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
29/12/2022
Data de registro
16/07/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/07/2024
Última transação
15/11/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
01
Localização do titular
BE
Examinador
BLANE, SUZANNE
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
R. D. (pessoa física)
Representantes
Timothy C. Bradley Carlson, Gaskey & Olds, P.C.
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical and veterinary preparations for medical or dietetic purposespreparations for treating infectious diseasesviral infectionsbacterial infectionsyeast infectionsfor treating cancerfor treating metabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases or conditions; pharmaceutical drugs for medical or dietetic purposesnamely for treating infectious diseasesviral infectionsbacterial infectionsyeast infectionsfor treating cancerfor treating metabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases or conditions; homeopathic preparations for use in the treatment of infectious diseasesviral infectionsbacterial infectionsyeast infectionsfor treating cancerfor treating metabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases or conditions; foodstuffs for medical purposesdietetic animal foodstuffs for medical purposes; dietetic foodstuffs for medical purposesnamely dietetic foods adapted for medical use; dietetic substances in the nature of confectionery substances adapted for medical purposes; food additives based on plant extracts for medical purposes; dietary food supplements for medical or dietetic purposes; dietary fiber for use as an ingredient for medical purposes; active pharmaceutical ingredients for medical purposesnamely drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; enzymessugarsvitaminsvitamin preparationsminerals and mineral preparations for medical purposes; vitamin tablets; vitamin drops; gummy vitamins; effervescent vitamin tablets; fortifying medicated beveragesbeverages with added vitamins for medical purposes; fortifying dietetic beveragesdietetic beverages with added vitamins for medical purposes; medicinal herbs and medicinal herb-based drinks; food supplements; pharmaceutical agents affecting metabolism; health food supplements for persons with special dietary requirements; pharmaceutical preparations for the prevention of diseases; nutraceuticals for use as a dietary supplement; infant formula; medical plasters; gauze materials for dressing; teeth filling material and dental wax; disinfectants; preparations for destroying noxious animals; fungicides and herbicides; sanitary preparations for medical use; dietetic substances adapted for medical use
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
28/03/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
17/01/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
26/12/2024
FIMP
FINAL DISPOSITION PROCESSED
26/12/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
17/10/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
16/07/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
16/07/2024
GPNX
NOTIFICATION PROCESSED BY IB
30/04/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
30/04/2024
PUBO
PUBLISHED FOR OPPOSITION
30/04/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/04/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/04/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/03/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/03/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/03/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/03/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/01/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/01/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/01/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/01/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/01/2024
RFNT
REFUSAL PROCESSED BY IB
07/11/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
17/10/2023
RFRR
REFUSAL PROCESSED BY MPU
17/10/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
30/09/2023
CNRT
NON-FINAL ACTION WRITTEN
29/09/2023
DOCK
ASSIGNED TO EXAMINER
26/09/2023
MAFR
APPLICATION FILING RECEIPT MAILED
28/02/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
24/02/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
23/02/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DUOSPORE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.